Good Documentation Practice Training (GDocP) for GMP Records

Opens with a question about the last GMP record you signed, then three FDA warning letters: batch record pages discarded and replaced in Navi Mumbai, equipment signed as clean with residues inside in Telangana, and records shredded before an inspection. Turns their lessons into three questions to ask of any record. Explains EU GMP Chapter 4 on instructions and records, introduces JKL Pharma Ltd in Mumbai and Singapore, and outlines the ten modules, practice questions, final exam and Certificate of Completion. You see why records are the only evidence that work was done the right way, and that records belong to the product and the patient. The module closes with a recap of the three cases, the difference between instructions and records, and how the course works.

What you will be able to do

• Explain the difference between instructions and records in GMP
• Ask three questions of any record: when, whether original, and whether true
• Recognise the documentation failures named in recent FDA warning letters

Why it matters

Every signature states a fact; knowing what inspectors found at other sites helps you write records that can be trusted.

Practice: Practice: Why documentation matters · 3 questions

Begins at a packaging site near Frankfurt, where an old printout of a line clearance procedure missed a check for loose labels. Covers the instruction types EU GMP Chapter 4 lists, from specifications to protocols and the site master file, then records, certificates and reports. Applies this at JKL Pharma for its metformin tablets, shows a tablet site in Dublin losing raw data on sticky notes, and ends with the common mistake, good practice and four checks. You see JKL Pharma's documents, from its corporate quality manual to procedures and its signature list, and the difference between a master record and an executed copy. A recap closes the module: instructions tell people what to do, records show what was done, and the rules apply to paper, electronic and hybrid records alike.

What you will be able to do

• Identify the main types of GMP instruction and record
• Recognise emails, photos and printouts that count as GMP records
• Check that only current, controlled instructions are in use

Why it matters

Working from an old printout or writing on a sticky note is where many record problems start; this shows you how to avoid both.

Practice: Practice: Instructions and records · 3 questions

Starts at a testing laboratory in Boston where two analysts signed with the same initials. Explains ALCOA+ as FDA and the WHO describe it, and how FDA maps each quality to the regulations. Covers attributable entries, signature lists, shared logins and scribes, then legible entries in permanent ink. Applies both at JKL Pharma in the MET500 batch record, the laboratory and the Singapore filling line, and shows legibility over time at a tablet site in Hong Kong. You see what each entry at JKL carries: the value, the unit, initials, the time and the balance number, and JKL's rule that if you cannot read it, you do not sign it. The module ends with the common mistake, good practice and a recap of the nine ALCOA+ qualities.

What you will be able to do

• Name the nine qualities of ALCOA+
• Make entries that trace to one person and to the equipment used
• Write entries that stay readable for the whole retention period

Why it matters

When an investigation asks who ran a failing test, your record must point to one person, and only one.

Practice: Practice: ALCOA+: who and how · 3 questions

Returns to the December 2025 warning letter, where operators filled in weights for work done by the previous shift. Explains what EU GMP Chapter 4, the US rules and the WHO say about recording at the time of the work, and why memory fails. Covers late entries, original data and true copies, and accurate values from calibrated equipment with checked calculations. Applies these in JKL Pharma's dispensary for MET500, then shows warning signs of non-contemporaneous records at a liquids site in Paris. You see how JKL marks a late entry with the actual date and time, and how its second person watches the balance display while the value is still visible. The module closes with the common mistake, good practice and a recap of the three qualities.

What you will be able to do

• Record values at the time of the work, with the real date and time
• Mark a late entry honestly instead of backdating it
• Check that a second-person verification is made against the source

Why it matters

A value written later may be right, but nobody can show it; recording at the time keeps your records checkable.

Practice: Practice: ALCOA+: when and what · 3 questions

Returns to the March 2020 warning letter, where a test was repeated four times and only the final result that met the specification was reported. Explains what the WHO and FDA say about keeping all data, including failing and suspect results, and investigating before invalidating any. Covers closing every field and counting pages, records that agree with each other, and protecting records for their retention period. Applies this at JKL Pharma and shows why enduring matters at a manufacturer in Sydney. You see how JKL closes every field, identifies each attachment with the batch number and step, and sets its own target of finding any batch record within an hour. A recap of the four qualities and the common mistake close the module.

What you will be able to do

• Keep all data, including failures and repeats, in the record
• Check that a record agrees with itself and with related records
• Store records so they last and can be found when needed

Why it matters

Every result belongs in the record, especially the unwelcome ones; a record with pieces missing tells the wrong story.

Practice: Practice: ALCOA+: the whole record · 3 questions

Opens at a tablet site in Tokyo, where correction fluid hid a drying temperature and the batch was held. Sets out five habits for making an entry, then how EU GMP Chapter 4 and the WHO expect corrections: one line through the error, the new value, initials, date and a reason. Applies JKL Pharma's procedure, including changes after review going through deviations, shows why reasons matter at a packaging site in London, and covers signature meanings and second-person checks. You see the four habits JKL's procedure requires, why the person who made an entry corrects it, and why a change after review goes through deviation, not a quiet correction. The module ends with the common mistake, good practice and a recap.

What you will be able to do

• Correct an entry so the original stays readable
• Apply the five habits for making an entry at the time of the work
• Explain what each signature and second-person check stands for

Why it matters

Mistakes happen to everyone; an honest, visible correction costs far less than a batch held for investigation.

Practice: Practice: Making and correcting entries · 3 questions

Returns to the December 2025 warning letter, with uncontrolled blank forms and two batch records issued for the same lots. Covers how documents are drafted, reviewed, approved, trained on and withdrawn, and how unique numbers, versions and effective dates identify the current one. Applies this at JKL Pharma: change requests, controlled copies, numbered replacement pages for the MET500 batch record and locked calculation templates. Shows why blank forms need control at a testing laboratory in New York. You see JKL's document numbering, such as its quality assurance procedures, its controlled copies tracked by location, and its review of each procedure at least every three years. A recap of controlled documents, controlled forms and page replacement closes the module.

What you will be able to do

• Identify the current version of a document from its number and effective date
• Issue and reconcile numbered blank forms through quality
• Replace a damaged page with the original kept and the reason recorded

Why it matters

A form anyone can copy is a form anyone can replace; controlling forms is what makes a record trustworthy.

Practice: Practice: Controlled documents and forms · 3 questions

Starts with the February 2025 warning letter, where equipment logged as cleaned still held residues. Lists what a batch record must show under the US rules and EU GMP Chapter 4: what was used, what was done and found, and who performed and checked each step. Walks through JKL Pharma's MET500 batch record, its reconciliations and a tablet press logbook, looks at filling records in Singapore, and shows a consistency problem at a packaging site in Dubai. You see how JKL checks the printed batch number and expiry date at the start and at set intervals, and an extract from the logbook for its second tablet press. The module closes with the common mistake, good practice and a recap.

What you will be able to do

• Check that a batch record shows what was used, done and found, and by whom
• Reconcile yields and labels, and investigate unexplained differences
• Fill in logbooks in time order so they agree with the batch record

Why it matters

If a batch is questioned years later, its record and logbooks must let anyone reconstruct what happened, step by step.

Practice: Practice: Batch records and logbooks · 3 questions

Starts with the March 2020 warning letter, where peak detection was disabled and unknown peaks went unreported. Lists what the US rules require in a laboratory record, from the sample description to all calculations and a second-person review. Applies this to JKL Pharma's assay worksheet for MET500 and its environmental monitoring plates, then covers true copies, retention for both markets and approved destruction. Shows a copy that was not true at a laboratory in Boston. You see an extract from JKL's assay worksheet, how JKL makes a true copy of a fading printout, and how its retention procedure applies whichever period is longest. A recap of laboratory records, true copies and retention closes the module.

What you will be able to do

• Check that a laboratory record holds complete data from all tests
• Make a true copy and verify it against the original
• Apply the longest retention period that any rule sets for a record

Why it matters

A laboratory record must show everything the instrument saw, and stay available for as long as any applicable rule requires.

Practice: Practice: Lab records, copies and retention · 3 questions

Opens with the December 2025 warning letter, where lots were distributed without documented review by the quality unit. Covers who reviews GMP records under the US rules and EU GMP Chapter 4, including audit trail review, and what a reviewer actually checks. Applies this at JKL Pharma, with time set aside for review and a confidential way to raise concerns, and shows why every question matters at a tablet site in Paris. Ends with the final exam and the certificate. You see what a reviewer is really signing for, why warning signs are questions to ask and never problems to fix quietly, and why speaking up early protects patients. The course closes with a recap and the move to the final exam.

What you will be able to do

• Review a record for completeness, correctness and truth before release
• Recognise warning signs in records that look too neat or too messy
• Raise a concern early instead of fixing a problem quietly

Why it matters

Review is the last chance to catch a problem before a batch reaches patients, even when quality staff are short.

Practice: Practice: Reviewing records · 3 questions